Literature DB >> 19301389

Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse.

Enyuan Shang1, Xiangyuan Wang, Duancheng Wen, David A Greenberg, Debra J Wolgemuth.   

Abstract

The BET subfamily of bromodomain-containing genes is characterized by the presence of two bromodomains and a unique ET domain at their carboxyl termini. Here, we show that the founding member of this subfamily, Brd2, is an essential gene by generating a mutant mouse line lacking Brd2 function. Homozygous Brd2 mutants are embryonic lethal, with most Brd2(-/-) embryos dying by embryonic day 11.5. Before death, the homozygous embryos were notably smaller and exhibited abnormalities in the neural tube where the gene is highly expressed. Brd2-deficient embryonic fibroblast cells were observed to proliferate more slowly than controls. Experiments to explore whether placental insufficiency could be a cause of the embryonic lethality showed that injecting diploid mutant embryonic stem cells into tetraploid wild-type blastocysts did not rescue the lethality; that is Brd2-deficient embryos could not be rescued by wild-type extraembryonic tissues. Furthermore, there were enhanced levels of cell death in Brd2-deficient embryos. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301389      PMCID: PMC2771124          DOI: 10.1002/dvdy.21911

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  63 in total

1.  Isolation and characterization of sex-linked female-sterile mutants in Drosophila melanogaster.

Authors:  M Gans; C Audit; M Masson
Journal:  Genetics       Date:  1975-12       Impact factor: 4.562

2.  The role of dosage of the region 7D1-7D5-6 of the X chromosome in the production of homeotic transformations in Drosophila melanogaster.

Authors:  M Gans; F Forquignon; M Masson
Journal:  Genetics       Date:  1980-12       Impact factor: 4.562

3.  Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis.

Authors:  Marc E Lenburg; Anupama Sinha; Douglas V Faller; Gerald V Denis
Journal:  J Biol Chem       Date:  2006-12-13       Impact factor: 5.157

4.  BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy.

Authors:  Deb K Pal; Oleg V Evgrafov; Paula Tabares; Fengli Zhang; Martina Durner; David A Greenberg
Journal:  Am J Hum Genet       Date:  2003-06-25       Impact factor: 11.025

Review 5.  Lysine acetylation and the bromodomain: a new partnership for signaling.

Authors:  Xiang-Jiao Yang
Journal:  Bioessays       Date:  2004-10       Impact factor: 4.345

6.  Bromodomain containing 2 (Brd2) is expressed in distinct patterns during ovarian folliculogenesis independent of FSH or GDF9 action.

Authors:  Rhonda K Trousdale; Debra J Wolgemuth
Journal:  Mol Reprod Dev       Date:  2004-07       Impact factor: 2.609

7.  E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.

Authors:  Rebecca J Greenwald; Joseph R Tumang; Anupama Sinha; Nicolas Currier; Robert D Cardiff; Thomas L Rothstein; Douglas V Faller; Gerald V Denis
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

8.  Identification of unique, differentiation stage-specific patterns of expression of the bromodomain-containing genes Brd2, Brd3, Brd4, and Brdt in the mouse testis.

Authors:  Enyuan Shang; Glicella Salazar; Thomas E Crowley; Xiang Wang; Rocio A Lopez; Xiangyuan Wang; Debra J Wolgemuth
Journal:  Gene Expr Patterns       Date:  2004-09       Impact factor: 1.224

9.  Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation.

Authors:  Shiraz Mujtaba; Yan He; Lei Zeng; Sherry Yan; Olga Plotnikova; Roberto Sanchez; Nancy J Zeleznik-Le; Ze'ev Ronai; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2004-01-30       Impact factor: 17.970

10.  Change in nuclear-cytoplasmic localization of a double-bromodomain protein during proliferation and differentiation of mouse spinal cord and dorsal root ganglia.

Authors:  ThomasE Crowley; Michele Brunori; Kunsoo Rhee; Xiangyuan Wang; Debra J Wolgemuth
Journal:  Brain Res Dev Brain Res       Date:  2004-04-19
View more
  72 in total

Review 1.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

Review 2.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

3.  BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo.

Authors:  Krishan Kumar; Brian T DeCant; Paul J Grippo; Rosa F Hwang; David J Bentrem; Kazumi Ebine; Hidayatullah G Munshi
Journal:  JCI Insight       Date:  2017-02-09

4.  Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.

Authors:  Anup Dey; Akira Nishiyama; Tatiana Karpova; James McNally; Keiko Ozato
Journal:  Mol Biol Cell       Date:  2009-10-07       Impact factor: 4.138

5.  Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.

Authors:  Janine M Lamonica; Wulan Deng; Stephan Kadauke; Amy E Campbell; Roland Gamsjaeger; Hongxin Wang; Yong Cheng; Andrew N Billin; Ross C Hardison; Joel P Mackay; Gerd A Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

6.  Characterization of BRD4 during mammalian postmeiotic sperm development.

Authors:  Jessica M Bryant; Greg Donahue; Xiaoshi Wang; Mirella Meyer-Ficca; Lacey J Luense; Angela H Weller; Marisa S Bartolomei; Gerd A Blobel; Ralph G Meyer; Benjamin A Garcia; Shelley L Berger
Journal:  Mol Cell Biol       Date:  2015-02-17       Impact factor: 4.272

7.  Functions of BET proteins in erythroid gene expression.

Authors:  Aaron J Stonestrom; Sarah C Hsu; Kristen S Jahn; Peng Huang; Cheryl A Keller; Belinda M Giardine; Stephan Kadauke; Amy E Campbell; Perry Evans; Ross C Hardison; Gerd A Blobel
Journal:  Blood       Date:  2015-02-18       Impact factor: 22.113

8.  Brd2 disruption in mice causes severe obesity without Type 2 diabetes.

Authors:  Fangnian Wang; Hongsheng Liu; Wanda P Blanton; Anna Belkina; Nathan K Lebrasseur; Gerald V Denis
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

9.  EPIGENETIC MECHANISMS IN MULTIPLE SCLEROSIS.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Rev Esp Escler Mult       Date:  2014-03

10.  BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.

Authors:  Anna C Belkina; Barbara S Nikolajczyk; Gerald V Denis
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.